AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32097124 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell-associated HIV-1 RNA
Number of subjects: 0
Study 32097124 — intervention group
Group type: COMPARATOR
Intervention: Plasma viral load (VL)
Number of subjects: 0
Study 34288635 — intervention group
Group type: EXPERIMENTAL
Intervention: DFT015
Number of subjects: 282
Study 34279747 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg of pseudoephedrine
Number of subjects: 60
Study 34279747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34789230 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorine treatment of water reservoirs
Number of subjects: 0
Study 34789230 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment of water reservoirs
Number of subjects: 0
Study 35091204 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral cough suppression therapy (BCST) plus 6 treatment sessions involving exposure to nebulized capsaicin in progressively larger concentrations (n = 8)
Number of subjects: 14
Study 35091204 — intervention group
Group type: COMPARATOR
Intervention: BCST plus 6 sessions of exposure to a single subthreshold dose of capsaicin (sham; n = 6)
Number of subjects: 14
Study 35587678 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized group received individualized brackets combined with Insignia appliance
Number of subjects: 71
Study 35587678 — intervention group
Group type: COMPARATOR
Intervention: Non-customized group received Damon Q self‐locking brackets
Number of subjects: 71
Study 35587678 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized group
Number of subjects: 71
Study 35587678 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 71
Study 32208828 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical symptoms in women
Number of subjects: 0
Study 32208828 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical symptoms in women
Number of subjects: 0
Study 35240703 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation group (daily use of a mindfulness‐focused meditation app)
Number of subjects: 60
Study 35240703 — intervention group
Group type: COMPARATOR
Intervention: Routine care group
Number of subjects: 60
Study 35240703 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation group
Number of subjects: 60
Study 35240703 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent meditation
Number of subjects: 60
Study 35240703 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation group (7 or more times)
Number of subjects: 60
Study 35588706 — intervention group
Group type: EXPERIMENTAL
Intervention: Perspectives app-based cognitive behavioral therapy (CBT) for 12 weeks
Number of subjects: 80
Study 35588706 — intervention group
Group type: EXPERIMENTAL
Intervention: Perspectives app-based cognitive behavioral therapy (CBT)
Number of subjects: 80
Study 35588706 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 80
Study 33769952 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment for 3 years
Number of subjects: 43
Study 32616017 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia closure technique with sutures placed 5 mm apart and 5 mm away from the fascia edge
Number of subjects: 274
Study 32616017 — intervention group
Group type: COMPARATOR
Intervention: Traditional fascia closure technique with sutures placed 1 cm apart and at least 1 cm away from the fascia edge
Number of subjects: 274
Study 36239675 — intervention group
Group type: EXPERIMENTAL
Intervention: OTT166 eyedrops (2.5% or 5%) administered BID for 28 days
Number of subjects: 44
Study 35305995 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐CARES (education+FIT)
Number of subjects: 326
Study 35305995 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐CARES Plus (C‐CARES+personalized coaching)
Number of subjects: 326
Study 33342524 — intervention group
Group type: EXPERIMENTAL
Intervention: Packed Promise intervention (monthly food boxes with $38 food value and $15 check for fruits and vegetables)
Number of subjects: 4750
Study 33342524 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4750
Study 36445957 — intervention group
Group type: COMPARATOR
Intervention: Group Z250 (control)/micro‐hybrid composite (Filtek Z250, 3M ESPE)
Number of subjects: 32
Study 36445957 — intervention group
Group type: EXPERIMENTAL
Intervention: Group EST/low‐viscosity bulk‐fill resin composite (Estelite Bulk Fill Flow, Tokuyama Dental Corp) + micro‐hybrid composite
Number of subjects: 32
Study 36445957 — intervention group
Group type: EXPERIMENTAL
Intervention: Group NOV/nanofiber‐reinforced low‐viscosity composite (NovaPro Flow, Nanova) + micro‐hybrid composite
Number of subjects: 32
Study 36445957 — intervention group
Group type: EXPERIMENTAL
Intervention: Group RIB/polyethylene fiber [Ribbond, Ribbond Inc] + micro‐hybrid composite
Number of subjects: 32
Study 32693833 — intervention group
Group type: COMPARATOR
Intervention: Vehicle-control (SD-101 0%)
Number of subjects: 87
Study 33661180 — intervention group
Group type: COMPARATOR
Intervention: Sham Electroconvulsive Therapy
Number of subjects: 0
Study 33661180 — intervention group
Group type: EXPERIMENTAL
Intervention: Other Novel Therapies
Number of subjects: 0
Study 33197917 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary self-monitoring
Number of subjects: 282
Study 33197917 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity recommendations
Number of subjects: 282
Study 33197917 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 282
Study 33197917 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study 34340161 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher NACM symptomatology
Number of subjects: 52
Study 34340161 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher arousal/reactivity
Number of subjects: 52
Study 32448358 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (Group A)
Number of subjects: 132
Study 32448358 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (Group B)
Number of subjects: 132
Study 36060146 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Guizhi Shaoyao Zhimu Decoction
Number of subjects: 100
Study 36060146 — intervention group
Group type: COMPARATOR
Intervention: Oral allopurinol tablets, 100 mg, 2 times a day
Number of subjects: 100
Study 32939850 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter
Number of subjects: 1142
Study 32939850 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandins
Number of subjects: 1142
Study 32975441 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of cannabis with 6.7% delta-9-tetrahydrocannabinol (THC)
Number of subjects: 10
Study 32975441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 36218395 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhomboid intercostal and subserratus plane (RISS) block + intravenous patient‐controlled analgesia
Number of subjects: 40
Study 36218395 — intervention group
Group type: COMPARATOR
Intervention: Intravenous patient‐controlled analgesia
Number of subjects: 40
Study 34816917 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined doxofylline and salbutamol treatment for 1 week
Number of subjects: 68
Study 34816917 — intervention group
Group type: COMPARATOR
Intervention: Doxofylline treatment for 1 week
Number of subjects: 68
Study 32241638 — intervention group
Group type: EXPERIMENTAL
Intervention: ledipasvir/sofosbuvir with ribavirin (RBV)
Number of subjects: 120
Study 32241638 — intervention group
Group type: EXPERIMENTAL
Intervention: sofosbuvir/RBV
Number of subjects: 120
Study 32241638 — intervention group
Group type: EXPERIMENTAL
Intervention: paritaprevir/ombitasvir/RBV
Number of subjects: 120
Study 36314766 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile healthcare apps
Number of subjects: 0
Study 36314766 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mobile app intervention)
Number of subjects: 0
Study 33089427 — intervention group
Group type: EXPERIMENTAL
Intervention: Topping-off (T/O) cohort with posterior dynamic stabilising devices (PDSs)
Number of subjects: 571
Study 33089427 — intervention group
Group type: COMPARATOR
Intervention: No topping-off (NoT/O) cohort
Number of subjects: 571
Study 35022004 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention menu with nudging and boosting elements (comic character, fun attractive name, information on low calorie density)
Number of subjects: 607
Study 35022004 — intervention group
Group type: COMPARATOR
Intervention: Control menu with standardized format including healthy target dish
Number of subjects: 607
Study 32347591 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency pulse (HFP) TLNS plus physical therapy (PT)
Number of subjects: 122
Study 32347591 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency pulse (LFP) TLNS plus physical therapy (PT)
Number of subjects: 122
Study 32347591 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled population (HFP + PT and LFP + PT)
Number of subjects: 122
Study 32347591 — intervention group
Group type: COMPARATOR
Intervention: Both groups (HFP + PT and LFP + PT)
Number of subjects: 122
Study 34864768 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Upper Limb Therapy-Integrated (MULT-I)
Number of subjects: 30
Study 34864768 — intervention group
Group type: COMPARATOR
Intervention: Home Exercise Program (HEP)
Number of subjects: 30
Study 33078636 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-Ingredient Performance Supplement (MIPS)
Number of subjects: 21
Study 33078636 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 21
Study 34247847 — intervention group
Group type: EXPERIMENTAL
Intervention: Lag screw fixation (two 1.5‐mm fully threaded bicortical screws using a lag technique)
Number of subjects: 24
Study 34247847 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlag screw fixation (two 1.5‐mm fully threaded bicortical nonlag screws)
Number of subjects: 24
Study 34247847 — intervention group
Group type: COMPARATOR
Intervention: Control (2 crossed 1.14‐mm K‐wires)
Number of subjects: 24
Study 32727613 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP with hydroxychloroquine (400mg daily for 4 days, then 400mg weekly for 6 months)
Number of subjects: 440
Study 32727613 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical appearance to hydroxychloroquine, same schedule)
Number of subjects: 440
Study 32727613 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP with hydroxychloroquine
Number of subjects: 440
Study 32727613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study 32727613 — intervention group
Group type: COMPARATOR
Intervention: Non-PrEP group (placebo)
Number of subjects: 440
Study 32727613 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmed COVID-19 cases
Number of subjects: 440
Study 35931991 — intervention group
Group type: EXPERIMENTAL
Intervention: i-HCH transitional care
Number of subjects: 0
Study 35931991 — intervention group
Group type: COMPARATOR
Intervention: usual transitional care
Number of subjects: 0
Study 35446066 — intervention group
Group type: EXPERIMENTAL
Intervention: Favorite music at 90, 120, and 150 bpm
Number of subjects: 83
Study 35446066 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfamiliar, genre-matched music at 90, 120, and 150 bpm
Number of subjects: 83
Study 35446066 — intervention group
Group type: EXPERIMENTAL
Intervention: Favorite music
Number of subjects: 83
Study 35446066 — intervention group
Group type: EXPERIMENTAL
Intervention: Favorite music at slowest tempo
Number of subjects: 83
Study 36435233 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine and dipyridamole
Number of subjects: 1000
Study 36435233 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1000
Study 36435233 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1000
Study 36435233 — intervention group
Group type: COMPARATOR
Intervention: No treatment with antithrombotic drugs
Number of subjects: 1000
Study 33466183 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg, maximum dose 24 mg)
Number of subjects: 105
Study 33466183 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 105
Study 32580752 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenhuang granule treatment twice a day for 14 days
Number of subjects: 160
Study 32580752 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 160
Study 35225115 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutropenic diet (n=21)
Number of subjects: 42
Study 35225115 — intervention group
Group type: COMPARATOR
Intervention: Standard Indian diet (n=21)
Number of subjects: 42
Study 33221589 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal medicine
Number of subjects: 29
Study 33221589 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 29
Study 33865841 — intervention group
Group type: EXPERIMENTAL
Intervention: 16.25 g fiber diet
Number of subjects: 60
Study 33865841 — intervention group
Group type: EXPERIMENTAL
Intervention: 32.5 g fiber diet
Number of subjects: 60
Study 33865841 — intervention group
Group type: EXPERIMENTAL
Intervention: 13C-mannitol
Number of subjects: 60
Study 33865841 — intervention group
Group type: EXPERIMENTAL
Intervention: lactulose
Number of subjects: 60
Study 33865841 — intervention group
Group type: EXPERIMENTAL
Intervention: rhamnose
Number of subjects: 60
Study 33865841 — intervention group
Group type: EXPERIMENTAL
Intervention: sucralose
Number of subjects: 60
Study 32119821 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened mosaic HIV‐1 vaccine schedules
Number of subjects: 0
Study 35369762 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (CPT) treatment
Number of subjects: 120
Study 35369762 — intervention group
Group type: COMPARATOR
Intervention: CPT with knee traction from full extension
Number of subjects: 120
Study 35369762 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT with knee traction from 90° flexion
Number of subjects: 120
Study 35369762 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT with knee traction from 20° flexion
Number of subjects: 120
Study 33443234 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood DNA methylation profiles in PLWH with airflow obstruction (FEV1/FVC<0.70)
Number of subjects: 161
Study 33443234 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood DNA methylation profiles in PLWH with airflow obstruction (based on FEV1/FVC<lower limit of normal)
Number of subjects: 161
Study 33443234 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood DNA methylation profiles in PLWH with airflow obstruction (FEV1)
Number of subjects: 161
Study 33443234 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood DNA methylation profiles in PLWH with airflow obstruction (FEV1/FVC)
Number of subjects: 161
Study 33443234 — intervention group
Group type: EXPERIMENTAL
Intervention: Global methylation in PLWH with airflow obstruction
Number of subjects: 161
Study 33443234 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood DNA methylation profiles in PLWH
Number of subjects: 161
Study 34011386 — intervention group
Group type: EXPERIMENTAL
Intervention: Long BPL RYGB
Number of subjects: 800
Study 34011386 — intervention group
Group type: COMPARATOR
Intervention: Short BPL RYGB
Number of subjects: 800
Study 36027848 — intervention group
Group type: COMPARATOR
Intervention: Resistance exercise (REx)
Number of subjects: 43
Study 36027848 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation combined with resistance exercise (NMES+REx)
Number of subjects: 43
Study 33238012 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-arm assisted THA
Number of subjects: 170
Study 33238012 — intervention group
Group type: COMPARATOR
Intervention: Manual THA
Number of subjects: 170
Study 32012217 — intervention group
Group type: EXPERIMENTAL
Intervention: Cordotomy
Number of subjects: 0
Study 32012217 — intervention group
Group type: COMPARATOR
Intervention: Control (sham procedure)
Number of subjects: 0
Study 35840851 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen Huoxue Formula (BSHXF) combined with lumbar traction
Number of subjects: 70
Study 35840851 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with lumbar traction
Number of subjects: 70
Study 32641343 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous high-dose vitamin C (HIVC) diluted in sterile water for 7 days
Number of subjects: 308
Study 32641343 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study 35978943 — intervention group
Group type: EXPERIMENTAL
Intervention: Music-with-movement intervention for 12 weeks
Number of subjects: 0
Study 35978943 — intervention group
Group type: EXPERIMENTAL
Intervention: Music-with-movement intervention for caregivers
Number of subjects: 0
Study 35978943 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation strategies
Number of subjects: 0
Study 35978943 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group interviews
Number of subjects: 0
Study 35978943 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of intervention by families
Number of subjects: 0
Study 35978943 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study 33320197 — intervention group
Group type: EXPERIMENTAL
Intervention: Identified and treated intrauterine adhesions (IUAs)
Number of subjects: 152
Study 33320197 — intervention group
Group type: COMPARATOR
Intervention: No intrauterine adhesions (IUAs)
Number of subjects: 152
Study 32619609 — intervention group
Group type: COMPARATOR
Intervention: sprifermin 100 μg q6mo
Number of subjects: 549
Study 32619609 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 549
Study 34739632 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback condition (diagnosed a case, rated confidence, received feedback)
Number of subjects: 69
Study 34739632 — intervention group
Group type: COMPARATOR
Intervention: Control condition (diagnosed a case, rated confidence, no feedback)
Number of subjects: 69
Study 33821515 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 58
Study 33821515 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT with written account (CPT+A)
Number of subjects: 58
Study 33821515 — intervention group
Group type: EXPERIMENTAL
Intervention: Written account only (WA)
Number of subjects: 58
Study 33821515 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-substance-involved SA)
Number of subjects: 58
Study 32240835 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone application (APP) for reinforced education starting 3 days before colonoscopy
Number of subjects: 500
Study 33019480 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy combined with multiple drilling and intramedullary drug injection (group EMI)
Number of subjects: 120
Study 33019480 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (group E)
Number of subjects: 120
Study 33019480 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple drilling combined with intramedullary drug injection (group MI)
Number of subjects: 120
Study 33019480 — intervention group
Group type: COMPARATOR
Intervention: Multiple drilling (positive control group; group M)
Number of subjects: 120
Study 33019480 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 34987480 — intervention group
Group type: EXPERIMENTAL
Intervention: Propylthiouracil (PTU)
Number of subjects: 36
Study 34987480 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole
Number of subjects: 36
Study 32127151 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (AG; n = 36)
Number of subjects: 72
Study 32127151 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG; n = 36)
Number of subjects: 72
Study 36040201 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaoketongbi Formula (XF)
Number of subjects: 68
Study 36040201 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin
Number of subjects: 68
Study 32202337 — intervention group
Group type: EXPERIMENTAL
Intervention: First responder's care package training through workshops
Number of subjects: 150
Study 32202337 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 150
Study 35369712 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 128
Study 35369712 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 128
Study 34520831 — intervention group
Group type: EXPERIMENTAL
Intervention: PMCb (paclitaxel plus Myocet®-nonpegylated liposomal doxorubicin plus carboplatin)
Number of subjects: 133
Study 34520831 — intervention group
Group type: COMPARATOR
Intervention: PM (paclitaxel plus Myocet®-nonpegylated liposomal doxorubicin)
Number of subjects: 133
Study 34520831 — intervention group
Group type: EXPERIMENTAL
Intervention: PMCb
Number of subjects: 133
Study 34520831 — intervention group
Group type: COMPARATOR
Intervention: PM
Number of subjects: 133
Study 34520831 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin addition
Number of subjects: 133
Study 36326639 — intervention group
Group type: EXPERIMENTAL
Intervention: Number lines
Number of subjects: 0
Study 36326639 — intervention group
Group type: COMPARATOR
Intervention: Icon arrays
Number of subjects: 0
Study 36326639 — intervention group
Group type: COMPARATOR
Intervention: Risk ladders
Number of subjects: 0
Study 36326639 — intervention group
Group type: COMPARATOR
Intervention: No visual display
Number of subjects: 0
Study 35013371 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printing-assisted percutaneous nephrolithotomy
Number of subjects: 90
Study 35013371 — intervention group
Group type: COMPARATOR
Intervention: Conventional B-ultrasound-guided puncture method
Number of subjects: 90
Study 34387225 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) program
Number of subjects: 84
Study 34387225 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 84
Study 32644833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 32644833 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ER-MPH (0.21 mg/kg equivalent of IR-MPH)
Number of subjects: 24
Study 32644833 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose ER-MPH (0.35 mg/kg equivalent of IR-MPH)
Number of subjects: 24